NextPharma is a leading European pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with a current footprint spanning five sites in Germany, two in France, one in the UK and one in Finland, and with healthcare logistics services in the DACH region. NextPharma supplies products globally, with eight of its nine sites FDA-approved. With expertise in solids, semi solids and non-sterile and sterile liquids, the company provides services from pharmaceutical development, clinical supplies, scale-up and process validation through to commercial manufacturing for a large range of dosage forms including tablets, capsules, granules, powders, pellets, gels, creams, sprays and syrups and a wide range of packaging solutions including blow-fill-seal, blisters, bottles, sachets, stick packs and tubes.

With the acquisition of two former Lonza sites in 2021 (Ploermel, France and Edinburgh, UK), we added to our services lipid-based formulations as soft gel and Liquid-filled hard-shell for pharmaceutical, high potent, hormonal, and nutritional products.